Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy...
-
Upload
baldwin-montgomery -
Category
Documents
-
view
213 -
download
0
Transcript of Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy...
Venous Thromboembolism (VTE)
Southern New Hampshire Medical Center
Lynda Pittenger, RN, CPHQKathy Helberg, BSN,RN, CPHQ
188-bed community hospital located in Nashua, NH; part of SNHHS with multi-specialty group practice, Foundation Medical Partners.
• Level III Trauma Center• > 45,000 ED visits /year • > 5,500 surgeries / year• 24/7 Hospitalist program• Minimally invasive surgery
program with daVinci• 11 Bed ICU
• Angioplasty / STEMI • 2 MRI and 2 CT scanners• Magnet (re-designated 2011)• American College of Surgeons
– Cancer, Breast Center• Stroke Program- AHA/GWTG-
Gold + award
VTE Measures Tracked and Trended at SNHMC
Process Measures:VTE 1: % Inpatients with VTE
prevention in place day of or dayVTE 2: % ICU Inpatients with VTE
prevention in placeVTE 3: % VTE patients on coumadin
who received overlap therapyVTE 4: % VTE patients on heparin
and PTT monitored as per order set
VTE 5: % VTE patients received d/c instructions re: coumadin
Outcome Measure:VTE 6: % Patients who develop VTE
during hospitalization
Process Measures;SCIP VTE 1: % surgery patients with
recommended VTE prophylaxis ordered
SCIP VTE 2: % surgery patients who received appropriate VTE prophylaxis within 24 hours prior to surgery to 24 hours after surgery
3
VTE Tools in Use at SNHMC
Prevention:• VTE Risk and Prevention Supplemental Order Set for admissions• Surgical Order Sets with built in mechanical /pharmacological
prevention• DVT prevention cue built into EMR to remind staff that if pt is not
ambulating, they are at risk.Treatment (for Dx of VTE):• Transitional Care Coordinators round on patients with VTE • Patient Education Information:
– DVT/ PE etiology, care, treatment and prevention– Coumadin Patient Education and Discharge Instruction– Nutrition Guidelines 4
Equipment Barriers
Inconsistent use of pneumatic compression stockings •Differing opinions by physicians on when to use recommendations - pneumatic + TEDs•Not enough equipment•Nurses concern with trip factor- may prevent patients from getting OOB. •Patient dissatisfaction - comfort
Solutions:Medical: Clarified order sets
to remove TEDs Surgical: Kept TEDs option on
order set and used in conjunction with SCD.
• Purchased more equipment• Promoted a healthy respect
for role of pneumatic compression stockings in VTE prevention– Memos, unit rounding
and staff education– Enhanced pre-op teaching
& expectations for patients
Medication Barriers
Variation in med use for chemoprophylaxis:
• Use of lovenox vs heparin for prevention– $$$$ difference– Daily vs. bid/tid dosing
• Physician concern with bleeding risk in peri op pts– Some surgeon hold outs– Hospitalists co-managing
“twitch”• NEW- anticoagulant for
arthroscopy-Rivaroxaban
Solutions:• Endorsed use of SQ heparin for
VTE prevention thru P&T
• Updated VTE evidence based order set
• Enhanced surgeon & hospitalist partnership
• Created a new order set in partnership with pharmacy
Medication Barriers cont.
Inconsistent use of post op surgical order sets – VTE anticoagulation prophylaxis during off-shifts / weekends.
Lack of clarity with overlap– CMS definition states
minimum 5 days and INR > than 2
– Physicians reluctant to continue overlap > 48-72H if INR > than 2
• Embedded VTE prompts in transfer orders from PACU to nursing units
Proposed Solution• Provide Physician education• Build cue into CPOE• Engage Transitional Care
Coordinators
SNHMC Performance Measures
8
Quality Measures SNHMCQ4 2011
SNHMCQ1 2012
VTE 1: % Inpatients with VTE prevention100% 100%
VTE 2: % ICU Inpatients with VTE prevention 100% 100%
VTE 3: % VTE patients on coumadin who
received overlap therapy89% 91.6%
VTE 4: % VTE patients on heparin and PTT monitored as per order set 100% 100%
VTE 5: % VTE patients received d/c instructions re: coumadin 100% 90.9%
VTE 6: % Patients who develop VTE during hospitalization
2 1
VTE 1&2: Sample PopulationVTE 3-6 All Cases
SNHMC SCIP Performance Measures
*Source: www.NHQualityCare.org - a partnership between the Foundation for Healthy Communitiesand the Northeast Health Care Quality Foundation Q310-Q211 (Composite does not include Card2 or Inf10)(National Average obtained from Hospital Quality Alliance Report)** Source: Northeast Health Care Quality Foundation - Qtr 4, 2011 (NHCQF Composite score includes the following: 1,2,3,4,6,9,10 VTE1&2, Card2)
Quality Measures SNHMCQ1
2012
SNHMC* 2011
SNHMC 2010
SNHMC 2009
NH*Q4 10- Q3 11
National*AverageQ4 10- Q3 11
National Benchmark(top 10% of
hospitalsQ1 11)
VTE 1- Recommended VTE Prophylaxis Ordered for Surgery Patients
96%
97%
91% 93% 98% 97% 99.9%
VTE 2 - Surgery Pts who Received Appropriate VTE Prophylaxis within 24 hrs Prior to Surgery to 24 hrs After Surgery
96%
97%
91% 92%
97% 96% 99.8%
What Can Others Learn From Our Journey?
• Engage a physician champion and form a multidisciplinary team
• Research best practice• Create evidence based tools - order sets and checklists• Test the tool- round, encourage feedback and make changes
– PDCA
• Roll out to a larger group• Implement and include 1:1 feedback • ROUND- to scan the environment for opportunities
10